Skip to main content
2026 ACVIM Forum Main banner
Icon Legend
This session is not on your agenda.
This session is on your agenda. Click again to remove it.
Presentation Icons
ACVIM Resident Research Award Eligible
ACVIM Resident Research Award Eligible
Additional Fees May Be Required
Additional Fees May Be Required
By Invite Only
By Invite Only
Capturing for On Demand
Capturing for On Demand
Cardiology Research Abstract Award Eligible
Cardiology Research Abstract Award Eligible
ERC Approved Lecture for ACVIM Residency
ERC Approved Lecture for ACVIM Residency
Poster
Poster
Livestream
Livestream
One Health
One Health
Pre-Registration Required
Pre-Registration Required
Research Abstract
Research Abstract
Specialty Symposium
Specialty Symposium
ACVIM Resident Research Award Winner
ACVIM Resident Research Award Winner
Cardiology Research Abstract Award Winner
Cardiology Research Abstract Award Winner
ViewAttendees 12

Small Animal Internal Medicine

In Person Only

Refining Diagnosis and Treatment of Canine Cushing’s Syndrome

Saturday, June 13, 2026
10:20 AM - 11:20 AM PT
Location: Summit SCC, Room 444
CE: 1.0 Medical Hours

Sponsored by 
ERC Approved Lecture for ACVIM Residency
Disclosure(s):
Andrew Bugbee, DVM, DACVIM (SAIM): Boehringer Ingelheim: Lectures for CE (Ongoing), On SGLT2 inhibitors and insulin (Ongoing); Dechra: Sponsoring lecture (Ongoing)
Presentation Description / Summary: This presentation will discuss evidence-based diagnostic strategies, treatment considerations, and individualized monitoring protocols as relating to the management of patients with hypercortisolism (Canine Cushing syndrome).

Learning Objectives:

  • Critically evaluate advanced diagnostic strategies for accurate diagnosis of hypercortisolism, type differentiation when appropriate, and considering the impact of co-morbidities on clinical decision making.
  • Compare and contrast options for tailoring treatment of canine hypercortisolism to individual patient need, including discussion of medical management, surgical intervention, and ideas for how to approach treatment-refractory cases.
  • Apply an evidence-based approach to effectively monitor of hypercortisolism treatment based on integrating recent research, comparison of protocols, and addressing adverse effects possibly associated with therapy.